Cardiac Troponin I Antibody [L9G3]

카탈로그 번호 F2021

인쇄

생물학적 설명

특이성 Cardiac Troponin I Antibody [L9G3]는 총 Cardiac Troponin I 단백질의 내인성 수준을 검출합니다.
배경 TNNC1에 의해 암호화되는 심장 트로포닌 C(cTnC)는 심장 얇은 필라멘트에서 이질삼량체 트로포닌 복합체(cTnI 및 cTnT 포함)의 161개 아미노산 Ca²⁺ 감지 서브유닛으로, 근세포에서 여기-수축 결합을 위해 근형질세망 Ca²⁺ 과도 현상을 액틴-미오신 교차 다리 순환과 연결합니다. 이는 단일 기능성 저친화도 EF-핸드 사이트 II(Asp29Leu/Asp31Ala 돌연변이를 통한 기능 상실 사이트 I로 인해)를 갖는 N-말단 조절 도메인(cNTnC, 잔기 1–77)과 두 개의 고친화도 Ca²⁺/Mg²⁺ 사이트 III/IV를 갖는 C-말단 구조 도메인(cCTnC, 잔기 84–161)으로 구성되며, 유연한 D/E 링커로 연결됩니다. 아포/닫힌 상태에서 cNTnC는 붕괴되지만, Ca²⁺ 결합은 cTnI 스위치 펩타이드(잔기 148–159) 도킹을 위한 소수성 패치 노출(Met48, Met51, Leu75, Phe77)을 유도합니다. 이완기 [Ca²⁺]i는 cNTnC를 아포 상태로 유지하며, cTnI 억제 영역(잔기 1–40)과 이동 도메인(164–210)이 트로포미오신을 통해 액틴의 미오신 결합 부위를 차단합니다. 수축기 Ca²⁺ 유입은 사이트 II에 결합하여 cNTnC를 열어 cTnI 스위치 헬릭스를 모집하고, 억제를 해제하며, 트로포미오신을 미오신 허용 M 상태로 이동시켜 힘 생성을 가능하게 합니다. PKA에 의한 cTnI Ser22/23 인산화는 이완 기능(lusitropy)에 대한 Ca²⁺ 민감도를 감소시킵니다. 돌연변이(예: HCM 관련 A8V/A31S는 안정화된 열린 상태를 통해 친화도를 증가시키고, DCM 관련 G159D는 파괴된 고정을 통해 감소시킴)는 비대성/확장성 심근병증의 근본적인 근섬유 Ca²⁺ 조절 이상을 유발하며, 순환하는 cTn 복합체는 급성 심근경색의 표준 바이오마커 역할을 합니다.

사용 정보

응용 WB, IP, IHC, FCM 희석
WB IP IHC FCM
1:100000 - 1:1000000 1:50 1:250 - 1:500 1:50
반응성 Human
출처 Rabbit Monoclonal Antibody MW 24 kDa
보관 완충액 PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
보관
(수령일로부터)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 60 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:100000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
IHC
Experimental Protocol:
 
Deparaffinization/Rehydration
1. Deparaffinize/hydrate sections:
2. Incubate sections in three washes of xylene for 5 min each.
3. Incubate sections in two washes of 100% ethanol for 10 min each.
4. Incubate sections in two washes of 95% ethanol for 10 min each.
5. Wash sections two times in dH2O for 5 min each.
6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
 
Staining
1. Wash sections in dH2O three times for 5 min each.
2. Incubate sections in 3% hydrogen peroxide for 10 min.
3. Wash sections in dH2O two times for 5 min each.
4. Wash sections in wash buffer for 5 min.
5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
9. Wash sections three times with wash buffer for 5 min each.
10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
12. Immerse slides in dH2O.
13. If desired, counterstain sections with hematoxylin.
14. Wash sections in dH2O two times for 5 min each.
15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
16. Mount sections with coverslips and mounting medium.
 

참조

  • https://pubmed.ncbi.nlm.nih.gov/26851561/
  • https://pubmed.ncbi.nlm.nih.gov/26232335/

적용 데이터

WB

Selleck 검증

  • F2021-wb
    Lane 1: Human Cardiac Troponin I Recombinant Protein